Table 10.
Six library compounds induce potent cell death of U-937 cells (human lymphoma) in both 24-ha and 72-hb experiments and enhance enzymatic activity of procaspase-3 in vitro.c
| Compound | U-937 72h IC50 (μM) | U-937 %Cell Death (24h, 7.5 μM) | %Procaspase-3 Activity (25 μM) |
|---|---|---|---|
![]() PAC-1 (1) |
3.8 ± 0.4 | 21 | 42 ± 1.8 |
|
S-PAC-1 (37) |
4.4 ± 0.7 | 23 | 4 ± 0.6 |
|
36{2,7} |
1.8 ± 0.2 | 90 | 53 ± 4.1 |
![]() 36{4,7} |
1.6 ± 0.2 | 53 | 64 ± 2.5 |
|
B-PAC-1 (36{18,7}) |
1.4 ± 0.2 | 97 | 36 ± 1.6 |
![]() 36{20,24} |
0.9 ± 0.03 | 83 | 82 ± 2.4 |
|
36{25,7} |
1.0 ± 0.04 | 50 | 69 ± 5.3 |
![]() 36{28,7} |
2.0 ± 0.2 | 70 | 60 ± 2.4 |
Cell viability determined by Annexin V-FITC/propidium iodide staining.
Biomass quantified using the sulforhodamine B assay.
Compounds were tested at a concentration of 50 μM with 1 μM procaspase-3 (wild-type) and 3.5 μM ZnSO4. Cleavage of the Ac-DEVD-pNA substrate was monitored at 405 nm and normalized to a DMSO-treated control (0%) and a zinc-free control (100%). [46]



